Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Arkansas for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Arkansas only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Arkansas (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Beata Filip-majewski (NPI 1083670749)

Field	Value
Entity Type	Individual
Organization	Beata Filip-majewski
Address	2231 Hill Park Cove
City	Jonesboro
State	AR
ZIP	72401
Taxonomy	Rheumatology Physician
NPI Enumerated	April 21, 2006

Payer Source	Total Paid
Medicare	$2M
Medicaid	$0

Key Findings

This provider reports $2M in total Medicare revenue and has no Medicaid billing on file, making the practice effectively single-payer (Medicare) in scale. The top three Medicare codes — J0129 ($644.3K, 31.3%), J0717 ($475.2K, 23.1%), and J9312 ($311.9K, 15.2%) — together account for 69.6% of the provider's Medicare revenue, indicating drug administration is the primary revenue driver.

The code mix is dominated by biologic injectables and infusion codes (J0129, J0717, J9312, J1602, J1745) alongside chemotherapy/infusion administration codes (96413, 96401, 96415), which is consistent with a rheumatology practice that operates an in-office infusion/service line to administer biologic and parenteral therapies. High-volume E/M (99213) and in-office lab codes (85025, 80053, 36415) further support a clinic model with frequent visits, phlebotomy, and on-site monitoring.

Revenue concentration is high: the top three drug administration codes account for 69.6% of Medicare revenue, indicating the practice’s financial performance is heavily dependent on reimbursement for biologic and infusion services rather than a broad mix of minor procedures or diagnostics. This concentration suggests sensitivity to changes in biologic drug reimbursement or utilization patterns.

On competitive standing for the largest biologic codes, the provider ranks in the upper-middle nationally but is not an outlier: J0129 ranks #154 of 1221 providers (87th percentile; typical, unremarkable volume), J0717 ranks #107 of 848 providers (87th percentile; typical, unremarkable volume), and J9312 ranks #71 of 317 providers (78th percentile; typical, unremarkable volume). These positions reflect meaningful but not dominant national participation in administration of these specific biologics.

The provider is an extreme outlier for office E/M volume on 99213 — 1.3K claims generating $77.2K and ranking #3205 of 457151 providers nationally (99th percentile; extreme outlier, far above typical national volume for this code) — which indicates a notably high throughput of established-patient visits compared with peers and supports the view of an active ambulatory clinic.

Chemotherapy and infusion administration activity is also materially above typical: 96413 ($58K) ranks in the 96th percentile (notably above typical national volume), 96401 ($34.1K) also sits in the 96th percentile (notably above typical national volume), and 96415 ($4.8K) is at the 92nd percentile (typical, unremarkable volume). This pattern signals regular use of prolonged infusions or systemic therapy administration in addition to biologic injections.

Ancillary services are provided in-house at above-typical levels: CBC (85025, $14.2K) and CMP (80053, $13.2K) both rank in the 96th percentile (typical, unremarkable volume), and phlebotomy (36415, $11.6K) ranks in the 98th percentile (typical, unremarkable volume). These data points are consistent with bundled visit workflows where labs are collected and processed as part of routine management of rheumatologic patients receiving biologics.

The NPI was enumerated on 2006-04-21 (~20 years ago), indicating an established billing presence that aligns with the developed infusion and office visit patterns seen in the Medicare data; longevity may also reflect an entrenched referral footprint that supports steady Medicare-only revenue.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

32 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0129	Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	18,950	$30	$644.3K
J0717	Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	118,800	$1	$475.2K
J9312	Injection, rituximab, 10 mg	4,950	$60	$311.9K
J1602	Injection, golimumab, 1 mg, for intravenous use	21,650	$10	$216.5K
J0897	Injection, denosumab, 1 mg	5,100	$20	$91.8K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	1,310	$60	$77.2K
J1745	Injection, infliximab, excludes biosimilar, 10 mg	2,420	$30	$62.9K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	670	$90	$58K
96401	The provider administers nonhormonal, antineoplastic chemotherapy drugs subcutaneously or intramuscularly to the patient.	680	$50	$34.1K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	240	$90	$21.5K

Showing 1–10 of 32

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 32 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Arkansas Distribution

Beata Filip-majewski — 4 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Arkansas

Full comparison — all codes billed, vs. state median

32 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0129	6	20	8,960	$30	$532.4K
J9312	4	10	6,500	$60	$393.8K
J0717	2	10	66,400	$1	$278.1K
J1602	5	10	15,300	$10	$185.4K
J1745	6	10	3,150	$30	$102.3K
J0897	50	160	2,580	$20	$89.7K
96413	20	80	380	$90	$36.6K
99214	1,515	4,300	130	$70	$18.8K
99213	40	4,180	100	$50	$9.6K
96401	3	60	120	$50	$8.6K

Showing 1–10 of 32

Related Providers

Other providers that share a Tax Identification Number (TIN) with Beata Filip-majewski, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Leslie Mccasland	AR	Rheumatology Physician	$1.9M	$0

Nearby Providers

Other providers in the same ZIP code as Beata Filip-majewski, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Focus, Inc	AR	Developmentally Disabled Services Day Training Agency	$0	$41.3M
St Bernards Hospital Inc	AR	General Acute Care Hospital	$0	$35.4M
Nea Therapy Providers, LLC	AR	Physical Therapist	$0	$26.9M
First Step Arkansas, LLC	AR	Early Intervention Provider Agency	$0	$23.8M
Communication Made Easy Inc	AR	Speech-Language Pathologist	$0	$17.8M
Baptist Memorial Hospital-jonesboro Inc	AR	General Acute Care Hospital	$0	$17M
The Logan Centers, Inc.	AR	Mental Health Clinic/Center (Including Community Mental Health Center)	$0	$16.5M
Arisa Health, Inc.	AR	Community/Behavioral Health Agency	$0	$15.6M
Kidsplace Learning Center Dba Kidspot	AR	Speech-Language Pathologist	$0	$14.1M
Miracle Kids Success Academy North	AR	Rehabilitation Clinic/Center	$0	$14M

Beata Filip-majewski — Billing Profile & Reimbursement Data

Sign up for Beata Filip-majewski — Billing Profile & Reimbursement Data policy alerts

Beata Filip-majewski — Billing Profile & Reimbursement Data

Sign up for Beata Filip-majewski — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References